BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24018791)

  • 1. Synthetic cannabinoids: a new frontier of designer drugs.
    Gunderson EW
    Ann Intern Med; 2013 Oct; 159(8):563-4. PubMed ID: 24018791
    [No Abstract]   [Full Text] [Related]  

  • 2. Designer drugs: a medicinal chemistry perspective.
    Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
    Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doors of deception: the diaspora of designer drugs.
    Kerwin J
    Drug Test Anal; 2011 Sep; 3(9):527-31. PubMed ID: 21960538
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic cannabis.
    Westin AA; Brede WR; Espnes KA
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2289. PubMed ID: 23736197
    [No Abstract]   [Full Text] [Related]  

  • 6. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Platteborze PL; Martin TM
    Mil Med; 2013 Jan; 178(1):v. PubMed ID: 23356108
    [No Abstract]   [Full Text] [Related]  

  • 8. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel psychoactive substances.
    Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
    Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical toxicology of emerging drugs of abuse--an update.
    Meyer MR; Peters FT
    Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic cannabinoid poisoning: A growing health concern.
    Phillips J; Lim F; Hsu R
    Nursing; 2016 Nov; 46(11):34-41. PubMed ID: 27673323
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
    Shanks KG; Dahn T; Behonick G; Terrell A
    J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Public Health in Combatting Synthetic Cannabinoid Use in Adolescents.
    Warren KE; Tay S; Wen LS
    J Adolesc Health; 2017 May; 60(5):483-486. PubMed ID: 28433118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic cannabinoids: analysis and metabolites.
    Elsohly MA; Gul W; Wanas AS; Radwan MM
    Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public Health Risk of Designer Psychotropic Drugs: Should PHASE Be Phased In?
    Greenblatt DJ
    Clin Pharmacol Ther; 2019 Dec; 106(6):1175-1176. PubMed ID: 31441050
    [No Abstract]   [Full Text] [Related]  

  • 19. [New synthetic drugs: legal highs in Spain (2010-2012)].
    Fornís Espinosa I; Vidal Giné C; Caudevilla Gálligo F; Ventura Vilamala M
    Med Clin (Barc); 2013 Feb; 140(4):189-90. PubMed ID: 22989678
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
    Ammann J; McLaren JM; Gerostamoulos D; Beyer J
    J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.